Universe · entity

PERCEPTIVE ADVISORS LLC

Institutional manager (13F) · CIK 1224962
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $4.7B
#IssuerValueShares
1PRAXIS PRECISION MEDICINES I$656M2,035,986
2CELCUITY INC$357M3,127,200
3ASCENDIS PHARMA A/S$350M1,531,421
4ROIVANT SCIENCES LTD$230M8,285,461
5CENTESSA PHARMACEUTICALS PLC$209M5,258,903
6RHYTHM PHARMACEUTICALS INC$206M2,373,795
7SPYRE THERAPEUTICS INC$191M3,783,225
8NUVALENT INC$162M1,580,505
9EDGEWISE THERAPEUTICS INC$139M4,423,974
10PROTAGONIST THERAPEUTICS INC$130M1,230,879
11APOGEE THERAPEUTICS INC$130M1,540,384
12TRAVERE THERAPEUTICS INC$123M4,142,551
13AMYLYX PHARMACEUTICALS INC$115M8,284,882
14IMMATICS N.V$102M10,383,456
15RELAY THERAPEUTICS INC$97M9,751,141
16INHIBRX BIOSCIENCES INC$97M1,442,707
17MEIRAGTX HLDGS PLC$89M10,326,103
18ZYMEWORKS INC$88M3,510,078
19SOLID BIOSCIENCES INC$86M11,906,646
20DYNE THERAPEUTICS INC$85M4,668,839
21BIOCRYST PHARMACEUTICALS INC$71M7,434,033
22ORUKA THERAPEUTICS INC$68M1,395,501
23ARTIVION INC$60M1,637,290
24NURIX THERAPEUTICS INC$58M3,710,877
25NAUTILUS BIOTECHNOLOGY INC$49M12,594,211
26CYTOMX THERAPEUTICS INC.$47M10,098,824
27ALTO NEUROSCIENCE INC$45M2,009,893
28ENGENE HOLDINGS INC$40M5,827,506
29IMMUNOVANT INC$40M1,597,383
30INTUITIVE SURGICAL INC$39M85,419
31IONIS PHARMACEUTICALS INC$38M504,000
32DAY ONE BIOPHARMACEUTICALS I$38M1,755,799
33ABIVAX SA$37M328,884
34CORVUS PHARMACEUTICALS INC$34M2,292,441
35REPLIGEN CORP$33M280,541
36JAZZ PHARMACEUTICALS PLC$32M170,000
37DAMORA THERAPEUTICS INC$32M1,223,000
38X4 PHARMACEUTICALS INC$28M6,737,648
39GUARDANT HEALTH INC$28M300,000
40BRIGHT MINDS BIOSCIENCES INC$28M377,544
41INVIVYD INC$27M20,859,303
42SIONNA THERAPEUTICS INC$26M658,439
43AXSOME THERAPEUTICS INC.$25M149,950
44REVOLUTION MEDICINES INC$25M258,600
45SAB BIOTHERAPEUTICS INC$25M6,431,743
46BELITE BIO INC$24M151,979
47TENAX THERAPEUTICS INC$23M1,447,782
48AXOGEN INC$23M697,312
49VIRIDIAN THERAPEUTICS INC$23M1,170,829
50ORCHESTRA BIOMED HLDGS INC$21M5,037,906
All filings on EDGAR ↗

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.